Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Z-Glu-OtBu

    • Product Name Z-Glu-OtBu
    • Alias OTBU-Z-GLU
    • Einecs 252-013-0
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    246825

    Product Name Z-Glu-OtBu
    Chemical Name N-Carbobenzyloxy-L-glutamic acid tert-butyl ester
    Molecular Formula C17H23NO6
    Molecular Weight 337.37
    Cas Number 14112-45-5
    Appearance White to off-white solid
    Melting Point 72-75°C
    Solubility Soluble in organic solvents such as dichloromethane, methanol
    Storage Conditions Store at 2-8°C, keep container tightly closed
    Purity Typically >98%
    Protecting Groups Carbobenzyloxy (Z) on amino, tert-butyl (OtBu) on carboxyl
    Optical Rotation [α]D20 ≈ +10° (c=1, CHCl3)
    Usage Peptide synthesis intermediate

    As an accredited Z-Glu-OtBu factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Z-Glu-OtBu is supplied in a sealed amber glass bottle, 5 grams, with tamper-evident cap and chemical hazard labeling.
    Shipping Z-Glu-OtBu is shipped in tightly sealed containers to prevent moisture and contamination. The chemical is packed according to safety regulations, typically in an insulated, cushioned package. It is shipped at ambient temperature unless otherwise specified, and handled as a non-hazardous material, ensuring product stability during transport.
    Storage Z-Glu-OtBu should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry place such as a desiccator. The storage temperature should typically be between 2–8°C (refrigerated). Proper labeling and segregation from incompatible materials are recommended to ensure stability and prevent contamination or degradation of the compound.
    Application of Z-Glu-OtBu

    Applications of Z-Glu-OtBu in Industrial Manufacturing

    As the original manufacturer of Z-Glu-OtBu, we supply this protected glutamic acid derivative for highly specialized downstream applications across advanced chemistry fields. Each sector utilizes the material in process-specific formulations, meeting strict industrial protocols and integrating into controlled batch or continuous production. Below, we provide a detailed breakdown of validated industry use cases, focusing on real-world scenarios based on actual customer formulas and regulatory compliance requirements.

    1. Peptide Synthesis for Pharmaceutical Intermediates

    Z-Glu-OtBu serves as a protected amino acid reagent, directly supporting solid phase and liquid phase peptide synthesis for APIs and advanced pharmaceutical intermediates. It delivers efficient γ-carboxyl protection and N-terminal blocking during elongation, preventing undesired side reactions in stepwise assembly of therapeutic peptides and small protein chains under cGMP conditions.

    Industry compliance standards

    • ICH Q7 GMP for Active Pharmaceutical Ingredients
    • USP and Ph. Eur. monographs for peptide substances
    • FDA 21 CFR Part 211 (for US-bound final APIs)
    • ISO 9001:2015 quality management for bulk intermediates

    Typical usage ratio

    • 0.95–1.10 molar equivalents per desired glutamic acid residue; ratio selected based on resin loading for SPPS, with adjustments for steric considerations or sequence length

    Downstream process integration

    • Direct loading onto support resin or addition to solution, during protected amino acid coupling cycle; followed by repeated deprotection/activation steps and final product cleavage

    Final product types

    • Pharmaceutical peptide APIs (e.g., GLP-1 analogues, anticoagulant peptides)
    • Custom synthetic peptides for research or preclinical drug candidates
    • Protected peptide fragments for further chemical modification

    2. Custom Oligopeptide Manufacturing for Diagnostics

    Diagnostic kit manufacturers employ Z-Glu-OtBu as a strategic intermediate during the synthesis of oligopeptides utilized in assay development, immunoassay standards, and peptide microarrays. The material’s selective tert-butyl ester protecting group supports orthogonal deprotection, facilitating high-fidelity sequence assembly and stable storage of synthetic peptide libraries under cleanroom production protocols.

    Industry compliance standards

    • ISO 13485:2016 quality management for medical devices
    • OECD Principles of Good Laboratory Practice (GLP)
    • International Organization for Standardization (ISO) 14644 cleanroom standards
    • Relevant technical standards for in vitro diagnostic peptides (e.g., CLSI C62)

    Typical usage ratio

    • 0.8–1.2 molar equivalents for glutamic acid residues, depending on manual vs. automated peptide assembly equipment and throughput requirements

    Downstream process integration

    • Incorporation at the residue extension stage within solid-phase/solution-phase peptide synthesis; final assemblies undergo stepwise automated deprotection and purification for analytical grade output

    Final product types

    • Peptide antigens for ELISA, western blot or immunohistochemistry applications
    • Capture and detection probes for lateral flow assays and biosensors
    • Synthetic peptide standards for clinical or environmental diagnostics

    3. Chemical Building Block for Protected Glutamic Acid Derivatives

    Chemical manufacturers specializing in protected amino acid derivatives use Z-Glu-OtBu as a core intermediate for further derivatization. The molecule enables synthesis of bifunctional linkers, unmasking of functional handles post-deprotection, and preparation of orthogonally protected glutamate building blocks, which support custom chemical libraries or fragment-based drug discovery pipelines.

    Industry compliance standards

    • REACH Registration, Evaluation, Authorization and Restriction of Chemicals (EU)
    • ISO 9001:2015 for specialty chemical manufacture
    • GHS/CLP compliance for labeling and material safety data
    • Internal validation: NMR and HPLC purity thresholds ≥98% for protected derivatives

    Typical usage ratio

    • Stoichiometric usage (1:1 ratio) relative to planned substructure; excess may be required for select orthogonal protection strategies or multi-step conversion yields

    Downstream process integration

    • Initial step as base material in solution-phase organic synthesis; introduced during multi-step protection/deprotection and conjugation reactions to generate target derivatives

    Final product types

    • Orthogonally protected glutamic acid building blocks (e.g., for Fmoc/tBu chemistry)
    • Protected intermediates for functionalized resin attachment
    • Bifunctional linkers for advanced small molecule synthesis

    4. Core Intermediate in Antibody-Drug Conjugate (ADC) Payload Linker Synthesis

    Several ADC developers integrate Z-Glu-OtBu in the assembly of glutamate-based linkers that connect cytotoxic payloads to monoclonal antibodies. Its well-defined protecting groups grant precise control during sequential linker formation, withstand orthogonal synthetic conditions, and release with mild deprotection. Manufacturers deploy the product within regulated GMP workflows to ensure linker homogeneity and payload conjugation efficiency.

    Industry compliance standards

    • ICH Q7 GMP for APIs/intermediates used in biologicals
    • FDA/EMA guidance for antibody-drug conjugate components
    • ISO 9001:2015 quality management for biopharma supply chain
    • USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products

    Typical usage ratio

    • 1.0 molar equivalent per linker unit; adjusted according to desired drug-to-antibody ratio and scale of linker-payload synthesis

    Downstream process integration

    • Introduced at the initial glutamic acid protection step for linker core assembly; processed through deprotection, payload activation, and final bioconjugation under sterile manufacturing conditions

    Final product types

    • Glutamic acid-based linker-payload modules for ADC manufacturing
    • Chemical linkers validated for therapeutic biologic conjugation
    • Research-grade ADC intermediates for preclinical evaluation

    5. Specialty Polymer and Hydrogel Synthesis

    Innovators in biomedical polymers use Z-Glu-OtBu for controlled synthesis of glutamate-containing copolymers and star polymers. The protected group strategy enables scalable polymerization without premature cross-linking or hydrolysis. End-users integrate the material for tuning mechanical or functional properties of medical hydrogels developed for wound dressings and controlled release matrices, under strict QC monitoring.

    Industry compliance standards

    • ISO 10993 biocompatibility evaluation of medical devices
    • ISO 13485:2016 quality management for medical device manufacturers
    • FDA 21 CFR Part 820 for polymeric medical components in the US
    • USP <88> Biological Reactivity Tests for Class VI plastics

    Typical usage ratio

    • Typically 3–15% by weight in copolymer feed, optimized to achieve targeted backbone composition and cross-link density; exact loading determined by monomer ratios and desired end-use performance

    Downstream process integration

    • Feeds into bulk co-monomer charge during solution or emulsion polymerization; undergoes deprotection and post-polymerization modifications prior to hydrogel formulation

    Final product types

    • Medical wound dressings based on glutamate-containing hydrogels
    • Bioresorbable coatings and scaffolds for tissue engineering
    • Controlled drug release polymer matrices for targeted delivery systems
    Free Quote

    Competitive Z-Glu-OtBu prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Z-Glu-OtBu: Practical Insights from a Chemical Manufacturer

    Meeting the Needs of Peptide Synthesis

    Z-Glu-OtBu plays a direct role in peptide coupling labs and manufacturing floors. We have seen requests for this protected amino acid grow over the last decade. Our Z-Glu-OtBu typically comes as a white crystalline powder, model designation based on L-Glutamic acid, N-benzyloxycarbonyl (Z) protected, gamma-tert-butyl ester form. This structure makes it compatible with common solid-phase and solution-phase routes, especially where careful selection of protecting groups influences yield and purity.

    Peptide chemists lean on Z-Glu-OtBu for stepwise assembly, particularly where the carboxyl side chain needs protection until global deprotection or selective modification. Z-protection offers resistance to racemization, and the tert-butyl group protects against premature side-chain reactions. That combination lets us and our clients keep synthesis steps clean, reduce by-products, and keep downstream purification manageable.

    Specifications Handled with Experience

    Our batches conform typically to a 98% or higher HPLC purity. Moisture and ash control is a big deal since peptide reactions are sensitive; we manage drying conditions tightly and oversee final milling, screening, and packaging ourselves. Consistency matters most when you want scalable results. Each lot comes with its own analysis, and we sample across the lot to guarantee customers get what they order every shipment.

    Standard particle size is fine enough for quick dissolution but coarse enough to avoid dusting—lab techs rarely appreciate powders that escape vials or scoop too light. We incorporate feedback from technicians who weigh and dissolve these materials day after day. What's in the bottle reflects years of adjustment, not just technical specs.

    Application in Synthesis Routes

    We first brought Z-Glu-OtBu into our product offerings after repeated customer requests with specific projects in mind: multi-step peptide chains where orthogonal protecting groups are essential. Chemists reached out describing problems with deprotection sequence interference—either premature removal or difficulty with downstream manipulation—so we made sure our process avoided traces of related byproducts that can act as nucleophiles.

    In Fmoc-based SPPS work, colleagues sometimes shift to Z/tert-butyl strategies if a problematic sequence contains easily modified side chains or requires acid-labile protection at particular positions. In solution-phase synthesis, preserving selectivity for final deprotection helps avoid entire re-runs of downstream purification. Purity of Z-Glu-OtBu feeds directly into overall yield.

    Some international customers have complicated syntheses for active pharmaceutical ingredient intermediates. They need to trust each protected amino acid entry step. Our shipments go through pre-qualified transport, using vacuum-sealed double bags, so lots arrive without moisture pickup or cross-contamination. Our records show that these steps cut waste and project delays to a minimum.

    Differences versus Other Protected Glutamic Acids

    A big question is how Z-Glu-OtBu differs from Fmoc-Glu-OtBu or Boc-Glu-OtBu. Each group brings its own set of advantages depending on the piece of chemistry. Z-protection resists strong base, which makes it helpful when your workflow needs selective deprotection under hydrogenolysis or mild acid conditions. For teams dealing with acid-sensitive sequences, the tert-butyl ester drops off more cleanly under TFA or related acid treatment compared to methyl or ethyl esters. Not every protecting group fits every route, but the Z/tert-butyl combination hits a sweet spot in several linear and cyclic peptide syntheses.

    Our chemists have compared alternate protected glutamic acids for lab-scale and pilot runs. Boc-Glu-OtBu often suits environments using hydrochloric acid cleavage, but stray water can complicate matters due to Boc’s hydrolytic instability. Fmoc-protection uses base-labile cleavage, but sometimes that step brings unintended reactions if your sequence or resin group can’t take strong base. The Z group, combined with tert-butyl, helps manage orthogonality—each protecting group responds to different conditions, so you can unmask side chains when you intend, rather than due to an accidental pH swing or overlooked contaminant.

    We’ve supplied Z-Glu-OtBu for both academic research and kilo-lot pharmaceutical projects. The most common positive feedback from these labs centers on how our purification minimizes colored impurities, which can smear downstream chromatography or throw off HPLC trace readings. Small changes in purification protocol altered our yield slightly, but the higher clarity in NMR and HPLC analysis warranted the trade-off. These kinds of practical tweaks only stick after feedback across hundreds of runs.

    Why Z-Glu-OtBu Remains a Reliable Choice

    Peptide chemistry depends on trustworthy intermediates. We have worked with labs who tried cheaper, less pure stocks, only to see sluggish couplings or persistent peaks in analytic traces that would not resolve without tedious repurification. Z-Glu-OtBu, when made with control at each synthesis and isolation step, removes that variable from the workflow. Reproducibility forms the backbone of chemistry—our customers count on feeding reliable intermediates into their processes.

    Some years ago, a customer came to us with recovery and solubility issues in their SPPS wheel. Comparing side-by-side runs, we traced the difference to inconsistent handling at the L-glutamic acid starting point in their previous supplier’s process—resulting in the formation of diastereomers and a faint, yellowish tint in longer peptide chains. Adjusting our own synthesis to hit tighter temperature and pH bounds at intermediate stages, and fine-tuning our extraction solvents, trimmed down the impurity profile and restored the desired solubility and reactivity. Consistency took close monitoring, not just mechanical repetition.

    Real results mean learning from small variations batch to batch. We run side-by-side pilot batches to cross-check lot stability, then hold back sample retains for up to 12 months to compare with customer feedback. This builds up an archive for troubleshooting, especially for customers tackling next-generation peptides or scale-ups into GMP domains. It’s not just a matter of chemical formula; each new set of hands and each workflow brings out its own challenges, and we thrive on finding ways to meet those.

    Supporting Research and Industry Scale

    Academic labs rely on our ability to size down without losing rigor. Sometimes an order covers a handful of syntheses for thesis projects, other times a full teaching lab. University users often want extra documentation on origin and handling, so we log extra batch history and maintain complete COAs for archival use. Corporates in scale-up mode demand lots that perform the same at every 50 gram, 500 gram, and kilo lot. Both groups need Z-Glu-OtBu to work the same at any scale, with minimal tweaks to established protocols.

    In the last ten years, more early-stage biotech projects ended up in larger manufacturing campaigns. Peptide ingredients destined for active pharmaceutical ingredients, diagnostic kits, or research peptides all flow from the same core starting materials. Downstream validation—identity, purity, and correspondence to reference standards—needs to happen quickly, so batch records for Z-Glu-OtBu tie directly to our own in-house and contract lab data. Each scaleup shows where process tweaks might help; sometimes a longer drying time, sometimes a gentler crystallization solve routine headaches. Only with years of feedback can we see which changes stick, but the goal is always robust supply.

    Practical Challenges in Z-Glu-OtBu Production

    Making Z-Glu-OtBu in consistent lots requires careful equipment cleaning, trace water control, and avoidance of cross-contamination. Our plant layout includes designated glassware and workstations for protected amino acids, with written logs for each cleaning sequence. Ambient conditions fluctuate year-round, and we track temperature and humidity to adapt batch timing and drying steps. We learned the hard way how minor missteps can affect side-chain ester stability—in the past, an overlooked cooling malfunction led to higher side-chain hydrolysis. Now, redundancy in monitoring helps us avoid lost batches.

    Maintaining the right reagent quality forms the foundation. Benzyloxycarbonyl chloride and tert-butanol, our two main starting reagents along with purified L-glutamic acid, show varying impurity profiles by supplier and date. We run in-house gas chromatography to record every new drum, rejecting those outside our defined windows. That kind of tight control reflects the lessons learned across many syntheses: impurity sources in the first steps multiply impacts with each downstream coupling, so best to cut problems before they start.

    Handling the dichloromethane and solvents in production brings its own safety and environmental challenges. Our shift has been towards improved air handling, solvent recovery, and automated transfer pumps to reduce employee exposure. These direct investments paid back in both employee satisfaction and reduced contaminant pickup. Retention rates in our technical production lines speak for themselves—keeping experienced operators familiar with the quirks of each product builds consistency.

    Logistics and Shipping: Lessons Learned

    Z-Glu-OtBu travels best in moisture-impermeable, non-reactive liners housed in robust high-density containers. We started double-bagging inside sturdy buckets after repeated shipments overseas arrived with cakes of solidified material or unexpected odors. Testing new packaging under both simulated heat and cold cycles helped minimize spoilage on arrival—especially where temperature-controlled storage isn’t guaranteed. Once, a critical shipment destined for a South Asian pharmaceutical project spent weeks impounded at port; after replacing the packaging, the recovered Z-Glu-OtBu still met spec, saving our customer a complete batch rerun.

    Customs labeling, Declaration of Content accuracy, and coordination with in-country logistics partners make the difference between rapid clearance and week-long delays. Over time, our logistics crew mapped out optimal harmonization codes, paperwork sequences, and backup shippers. Customers updated us about what worked and what didn’t. Detailed internal checklists became part of our lot release process, closing the loop between lab, warehouse, and final destination.

    Feedback-Driven Adjustments and Customer Relationships

    Chemists using Z-Glu-OtBu in fast-paced environments—like CROs or diagnostic kit companies—offered feedback that drove several adjustments. Texture and dissolution rate topped the list early; technicians complained about lumps or partial dissolution in polar solvents. Tweaking our drying and milling regimes flattened these performance issues. We keep a running log of such feedback, cross-referenced with batch numbers and production logs, making each new batch stronger.

    Some end users with automated liquid handling wanted to avoid dust clouds in their hood—helpful suggestions led to shorter, slower pour spouts and modified antistatic treatments at our packing stations. Larger-scale users flagged the importance of repeat deliveries always matching their reference material; we established internal retain libraries so we could back-check every new batch sample against historical standards.

    We work directly with project chemists—people keenly interested in lot-to-lot differences, side product formation, or odd residue on glassware. Their firsthand observations fine-tune our QC and point out when minor issues in one batch might become headaches in scale-up or validation. It’s not a one-way street: we supply technical guidance on reconstitution, storage, and transfer, especially for new users. Many times, we have seen lab teams advise us about unexpected peaks or color shifts in coupled peptides. Every report helps us trace causes, fix processes, and share knowledge back to customers.

    Trusted, Experienced Production for Modern Peptide Science

    Making protected amino acids for peptide synthesis takes more than following a recipe. Z-Glu-OtBu’s value grows from experience—attention to raw material sourcing, tight controls on each step, and active relationships with chemists worldwide. We do not rest on standard specification sheets or marketing copy. The real test comes from downstream results: complete couplings, clean chromatography peaks, and products with little need for post-synthesis troubleshooting.

    Direct communication ensures users get consistent product and keeps us grounded in the chemistry happening outside our own plant. Research and manufacturing groups give us new problems, and every improvement in our Z-Glu-OtBu process comes from open dialogue. We keep investigating better reagent prep, cleaner workups, smarter packaging, and ever-greater transparency at each link in the chain. That’s the only way to supply a product reliable enough for world-class peptide chemistry now and in the future.